Argenica Therapeutics Limited (AGN.AX)
AUD 0.68
(0.0%)
AUD 0.68
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.05 AUD | 3.64% |
| 2023 | -0.06 AUD | 0.54% |
| 2022 | -0.06 AUD | -292.2% |
| 2021 | -0.01 AUD | -171.15% |
| 2020 | -0.01 AUD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | -0.02 AUD | -33.1% |
| 2024 Q4 | -0.02 AUD | 0.0% |
| 2024 FY | - AUD | 4.0% |
| 2024 Q2 | -0.01 AUD | -100.0% |
| 2024 Q1 | -0.01 AUD | 80.86% |
| 2023 Q2 | -0.02 AUD | -98.89% |
| 2023 FY | - AUD | 0.54% |
| 2023 Q4 | -0.04 AUD | -100.54% |
| 2023 Q3 | -0.02 AUD | -3.35% |
| 2023 Q1 | -0.01 AUD | 71.43% |
| 2022 FY | - AUD | -292.2% |
| 2022 Q3 | -0.02 AUD | 34.31% |
| 2022 Q2 | -0.02 AUD | -99.17% |
| 2022 Q1 | -0.01 AUD | 20.0% |
| 2022 Q4 | -0.03 AUD | -100.64% |
| 2021 FY | - AUD | -171.15% |
| 2021 Q2 | 0.00 AUD | -25.0% |
| 2021 Q4 | -0.02 AUD | -16.28% |
| 2021 Q1 | 0.00 AUD | 123.08% |
| 2021 Q3 | -0.01 AUD | -1533.33% |
| 2020 Q2 | - AUD | 0.0% |
| 2020 FY | - AUD | 0.0% |
| 2020 Q4 | -0.01 AUD | 0.0% |